1. Catalogs
  2. Randox Laboratories
  3. Cardiac Risk Multiplex Array

Cardiac Risk Multiplex Array

Cardiac Risk Multiplex Array

Cardiac Risk Multiplex Array

Product catalog summary
Introduction
The Cardiac Risk Prediction Array is a comprehensive tool for assessing genetic risk for Coronary Heart Disease (CHD). It combines genetic data with common risk factors to provide a more accurate risk assessment.

Algorithm and Genetic Risk Score
The array utilizes Genome Wide Association Studies (GWAS) findings, requiring genotyping of 19 CHD 'at risk' SNPs. A rapid array developed by Randox allows simultaneous genotyping, reducing time and cost. The genetic risk score is calculated using an algorithm that weights each SNP and combines it with common risk factors to determine overall CHD risk.

Common Risk Factors
Traditional risk assessment tools like PROCAM and Framingham have low predictive value and do not account for genetic predisposition. The Cardiac Risk Prediction Array addresses this gap by integrating genetic data.

Protocol
The process involves four steps: extraction of genomic DNA, amplification via multiplex PCR, hybridization to a biochip array, and detection using the Evidence Investigator analyser. This streamlined protocol allows for genotyping within one day.

Benefits
The array provides a rapid, reliable method for genetic risk assessment, allowing for better classification and targeted preventative actions. It also identifies patients at risk for statin-induced myopathy, aiding in personalized treatment decisions.

Laboratory Advantages
The array supports simultaneous genotyping of 19 SNPs, with a simple protocol optimized for molecular laboratories. It processes 36 patient samples per kit and offers easy result interpretation with dedicated software.

Evidence Investigator
This semi-automated biochip analyser enhances laboratory efficiency through multiplexing, reducing time and costs associated with multiple tests. It includes features for result traceability and extensive quality control.

Ordering Details
The Cardiac Risk Prediction Array is available in packages of 72 biochips, with the Evidence Investigator Analyser sold separately. Note that extraction reagents are not included.
See more

Catalog excerpts

Cardiac Risk Multiplex Array-1

Cardiac Risk Prediction Array Comprehensive genetic risk assessment for CHD

 Open the catalog to page 1
Cardiac Risk Multiplex Array-2

Cardiac Risk Prediction Array Simultaneous genotyping of 19 SNPs for a reliable CHD risk assessment Introduction Coronary Heart Disease (CHD) is the leading cause of death in the developed world and its prevention is a core activity in general practice worldwide. For example, clinical guidelines from the Joint Cardiac Societies and NICE in the UK recommend that patients at greater than 20% risk of CHD in the next ten years should be classified as high risk and considered for intensive lifestyle intervention and lipid lowering therapy,1 primarily the prescription of statins. Current CHD risk assessment...

 Open the catalog to page 2
Cardiac Risk Multiplex Array-3

Response to statin treatment A fur ther impor tant SNP which can predict response to par ticular statin therapies has been included in the array. Individuals who are homozygous (frequency =0.13) for the risk allele are 17 times more likely to suffer from statin-induced myopathy when treated with high doses of simvastatin.8 Identifying patients with a higher risk of suffering statin-induced myopathy would allow clinicians to make more informed decisions when prescribing lipid lowering therapies. Cardiac Risk Prediction Array Protocol Step 1 Extraction Genomic DNA extracted from blood/saliva Save...

 Open the catalog to page 3
Cardiac Risk Multiplex Array-4

Evidence Investigator Multiplexing...proven, perfected, evolved The Evidence Investigator is a semi-automated, benchtop biochip analyser which offers complete patient profiling. Save time and costs Multiplexing reduces time, labour and reagents associated with multiple individual tests Increase throughput For greater laboratory efficiency Consolidation Of immunoassays and molecular diagnostics, improving laboratory efficiency Result traceability Chain of custody features and bar coded reagents No hidden costs Package includes imaging module, PC and imaging software, thermoshaker, biochip carrier...

 Open the catalog to page 4

All Randox Laboratories catalogs and technical brochures

  1. Acusera 24.7

    24  Pages

  2. sdLDL-C

    8  Pages

  3. RX modena

    20  Pages

  4. RX misano

    20  Pages

  5. RX Daytona Plus

    20  Pages

  6. Rx Imola

    20  Pages

  7. RX Monaco

    20  Pages

  8. VeraSTAT-V

    16  Pages

  9. VERASTAT

    16  Pages

  10. Qnostics

    52  Pages

  11. Linearity sets

    12  Pages

  12. Antioxidants

    16  Pages

  13. VIVALYTIC

    30  Pages

  14. HbA1c

    2  Pages

  15. Preparing QC

    1  Page

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.